Stay updated on Pembrolizumab in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in HCC Clinical Trial page.

Latest updates to the Pembrolizumab in HCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows Revision: v3.6.6, replacing the previous revision tag, indicating a minor maintenance update. It does not change study details or how users interact with the page.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page version.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a new deployment of the study page.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page shows a new Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor internal update to the page's version/metadata without altering the study content.SummaryDifference0.1%

- Check82 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, indicating a newer version of the site’s code or template. The change appears to be a backend patch rather than a modification to study content or user-facing data.SummaryDifference0.1%

- Check97 days agoChange DetectedThe study page now indicates that enrollment is closed, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) along with a revision update to v3.6.0 and formatting adjustments to the Intervention/Treatment label.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HCC Clinical Trial page.